Back
Leveraging Genomic Sequence-to-Function Language Models for the Design of Antisense Oligonucleotides
Wednesday, January 27, 2027 at 12:30 PM to 1:00 PM · 30 min. (Europe/London)
AI in Drug Discovery Stage
Day 1 - Wednesday 27th January
AI
AI in Drug Discovery
Drug Discovery
Information
This session will explore:
An introduction to Genomic sequence-to-function language models
Why genomic sequence-to-function models are promising for ASO design
Preliminary results: reproducing the effect of Nusinersen on the SMN2 gene using
the Borzoi model
Limitations and perspectives
Speakers
Majd Saleh
Senior Data Scientist
Servier Institute of Therapeutic Innovation